ArticleScientific reports2025
Complement and diverse enrichment of antibodies in intraluminal thrombi from abdominal aortic aneurysms may contribute to increased inflammation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abdominal aortic aneurysms (AAA) often contain an intraluminal thrombus (ILT) which may contribute to aneurysm growth and rupture, but the mechanisms are not well understood. We hypothesized that complement and antibodies play a central role in the immune reactions within ILT from AAA. We quantified pre-specified proteins from complement and other defense systems, including coagulation, fibrinolysis, neutrophils, relevant proteinases and inhibitors, as well as immunoglobulins in ILT (n = 7), using fresh thrombi for comparison (n = 7). Protein analysis was performed using liquid chromatography in tandem with mass spectrometry, permitting simultaneous protein detection with comparable quantitative results, and antibody diversity characterization. The results indicated complement activation (classical and lectin pathways), coagulation (contact pathway), and degranulation including proteinase release from neutrophils in the ILT, with protein enrichment compared to fresh thrombi. Inhibitors of these systems were also present. In the ILT, 151 different immunoglobulin heavy chain and 144 different light chain variable regions were detected. Corresponding numbers in the controls were 25 and 26. Immunohistochemistry confirmed terminal complement activation and substantial presence of IgG in the ILT, which also contained IgM and IgA. These results are suggestive of a complex immunological process with activation of many defense systems, and antibody enrichment in the ILT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.